Published in JAMA Oncol on July 01, 2016
Prostate biopsy characteristics: A comparison between pre- and post- United States Preventive Service Task Force Prostate Cancer Screening Guidelines of 2012. Rev Urol (2017) 0.75
Knowledge, attitudes and screening practices regarding prostatic diseases among men older than 40 years: a population-based study in Southwest Nigeria. Pan Afr Med J (2017) 0.75
Expected population impacts of discontinued prostate-specific antigen screening. Cancer (2014) 1.24
Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies. JAMA Oncol (2016) 1.04
National trends in the management of low and intermediate risk prostate cancer in the United States. J Urol (2014) 0.95
Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer. Cancer Epidemiol Biomarkers Prev (2015) 0.88
Overdetection of recurrence after radical prostatectomy: estimates based on patient and tumor characteristics. Clin Cancer Res (2014) 0.84
Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy. Cancer (2015) 0.82
Effect of Screening Mammography on Cancer Incidence and Mortality. JAMA Intern Med (2015) 0.81
Screening men at increased risk for prostate cancer diagnosis: Model estimates of benefits and harms. Cancer Epidemiol Biomarkers Prev (2016) 0.78
Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States. Cancer Epidemiol Biomarkers Prev (2017) 0.77
Is prostate cancer different in black men? Answers from 3 natural history models. Cancer (2017) 0.75
Missteps in Current Estimates of Cancer Overdiagnosis. Acad Radiol (2016) 0.75
Insights from the PLCO trial about prostate cancer screening. Cancer (2016) 0.75